Antidepressant discontinuation syndrome
- PMID: 16913164
Antidepressant discontinuation syndrome
Abstract
Antidepressant discontinuation syndrome occurs in approximately 20 percent of patients after abrupt discontinuation of an antidepressant medication that was taken for at least six weeks. Typical symptoms of antidepressant discontinuation syndrome include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal. These symptoms usually are mild, last one to two weeks, and are rapidly extinguished with reinstitution of antidepressant medication. Antidepressant discontinuation syndrome is more likely with a longer duration of treatment and a shorter half-life of the treatment drug. A high index of suspicion should be maintained for the emergence of discontinuation symptoms, which should prompt close questioning regarding accidental or purposeful self-discontinuation of medication. Before antidepressants are prescribed, patient education should include warnings about the potential problems associated with abrupt discontinuation. Education about this common and likely underrecognized clinical phenomenon will help prevent future episodes and minimize the risk of misdiagnosis.
Similar articles
-
FINISH: remembering the discontinuation syndrome. Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances, and Hyperarousal (anxiety/agitation).J Clin Psychiatry. 1998 May;59(5):255. J Clin Psychiatry. 1998. PMID: 9632038 No abstract available.
-
Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs.J Psychosoc Nurs Ment Health Serv. 2010 Jul;48(7):9-12. doi: 10.3928/02793695-20100527-98. Epub 2010 Jun 22. J Psychosoc Nurs Ment Health Serv. 2010. PMID: 20608581
-
Antidepressant noncompliance as a factor in the discontinuation syndrome.J Clin Psychiatry. 1997;58 Suppl 7:31-5; discussion 36. J Clin Psychiatry. 1997. PMID: 9219492
-
Extended antidepressant maintenance and discontinuation syndromes.Depress Anxiety. 1998;8 Suppl 1:43-53. doi: 10.1002/(SICI)1520-6394(1998)8:1%3C43::AID-DA9%3E3.0.CO;2-6. Depress Anxiety. 1998. PMID: 9809213 Review.
-
[Antidepressant agents and discontinuation syndrome].Duodecim. 2002;118(1):21-4. Duodecim. 2002. PMID: 12228992 Review. Finnish. No abstract available.
Cited by
-
The Potential Use of Monocyte-to-High-Density Lipoprotein Ratio as a Chronic Inflammatory Marker in Major Depressive Disorder.Psychiatry Clin Psychopharmacol. 2023 Sep 1;33(3):187-192. doi: 10.5152/pcp.2023.22518. eCollection 2023 Sep. Psychiatry Clin Psychopharmacol. 2023. PMID: 38765305 Free PMC article.
-
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.J Psychopharmacol. 2024 May;38(5):458-470. doi: 10.1177/02698811241237870. Epub 2024 Mar 22. J Psychopharmacol. 2024. PMID: 38520045 Free PMC article. Clinical Trial.
-
Antidepressant discontinuation and the role of the pharmacist.Can Pharm J (Ott). 2023 Jul 24;156(5):251-256. doi: 10.1177/17151635231188340. eCollection 2023 Sep-Oct. Can Pharm J (Ott). 2023. PMID: 38222887 Free PMC article. No abstract available.
-
Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis.Mol Neurobiol. 2024 Jan;61(1):465-475. doi: 10.1007/s12035-023-03555-w. Epub 2023 Aug 26. Mol Neurobiol. 2024. PMID: 37632679
-
Major depressive disorder.Nat Rev Dis Primers. 2023 Aug 24;9(1):44. doi: 10.1038/s41572-023-00454-1. Nat Rev Dis Primers. 2023. PMID: 37620370 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
